A movement coach argues that whatever role peptides play in recovery, skills like getting up off the floor without your hands still have to be trained.
Recap by typeshit. Post by @vanja.moves on Instagram.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Ravikiran Bodlapati and Frank Burslem argue eligibility, access and uptake will decide how far GLP-1 sales can grow from today.
Tirzepatide alone reached 14.8% in the same trial. The catch: up to 27% of people on the combination quit over side effects, per the Motley Fool writeup.
Loading…